Concentration-response function (95%CI) Health outcomes Australian UK Europe US EPA WHO Recommended Long-term outcomes(annual average concentration) Mortality All cause n/a1 n/a n/a No effect n/a No CRF () recommended. () Age: 30-99 years. Annual 1-hour average. Cardiopulmonary n/a n/a n/a Cardiovascular n/a No CRF disease: No effect recommended. () () Age: 30-99 years. Annual 1-hour average. Ischaemic heart n/a n/a n/a n/a n/a No CRF disease recommended. Lung cancer n/a n/a n/a n/a n/a No CRF recommended. Respiratory n/a n/a n/a 1.040 (1.013-1.067) n/a No CRF per 10 ppb recommended. () () Insufficient evidence ICD9: 460-519 - only 1 study. Age: 30-99 years. Annual 1-hour average.
Concentration-response function (95%CI) Health outcomes Australian UK Europe US EPA WHO Recommended Long-term outcomes(annual average concentration) Mortality All cause n/a1 n/a n/a No effect () () Age: 30-99 years. Annual 1-hour average. n/a No CRF recommended. Cardiopulmonary n/a n/a n/a Cardiovascular disease: No effect () () Age: 30-99 years. Annual 1-hour average. n/a No CRF recommended. Ischaemic heart disease n/a n/a n/a n/a n/a No CRF recommended. Lung cancer n/a n/a n/a n/a n/a No CRF recommended. Respiratory n/a n/a n/a 1.040 (1.013-1.067) per 10 ppb () () ICD9: 460-519 Age: 30-99 years. Annual 1-hour average. n/a No CRF recommended. Insufficient evidence - only 1 study.
health-report.docx